About us
Nabros is a leading privately held, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India, incorporated in 1983 and taken over by Shri Navneetbhai Shah in 1997.
Nabros is the 1st manufacturer of Phospholipids in India. We presence in cardiovascular system (CVS), diabetology, respiratory care, gastroenterology, pain management as well as other therapeutic segments.
Nabros' success and incessant growth lies in execution of successful and strategic moves made in the areas of manufacturing, R & D and global operations over three decades.
Nabros has strong presence in more than 30 countries worldwide with marketing and distribution infrastructure in Central & Latin America, Africa, Asia - Pacific as well as CIS and MENA countries.
Nabros' global strategy includes alliances with leading Global Pharma Companies for development and distribution of products as well as direct product distribution.
Nabros has made a substantial commitment to its Phospholipids Business Unit in terms of creating R&D, manufacturing and marketing capabilities for its EPL portfolio. Continual R & D initiatives have strengthened niche and complex product offerings in International markets.
Nabros has made strategic investments in manufacturing facilities. Our facilities conform to the most stringent international cGMP norms and have received approvals from various prominent international regulatory bodies.
Nabros is the only manufacturer of Essential Phospholipids bulk drug in India, used for the treatment of Liver malfunctioning inernally as medicine, as food supplement and emollient in external preparation.
